All posts by: SetPoint Medical (Admin)

About SetPoint Medical (Admin)

SetPoint Medical Presents Positive Data from its Clinical Study of Bioelectronic Medicine for Treatment of Crohn’s Disease

  Proof-of-Concept Data Presented at Digestive Disease Week in Washington D.C. Valencia, CA  – June 11, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced the presentation of positive clinical results from the company’s proof-of-concept study using bioelectronic medicine to treat Crohn’s disease, a debilitating condition caused … Continue reading

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

  Commercialization Expertise Beneficial as SetPoint Advances its Clinical Program Valencia, CA  – May 21, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing  bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing.  Mr. Shah has more than a decade of experience developing … Continue reading

SetPoint Medical Announces U.S. Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis

  Trial Assesses Proprietary New Device that Delivers Doses of Electricity to Treat Rheumatoid Arthritis; Builds on First-in-Human Data Valencia, CA – March 26, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, today announced it has launched a pilot trial for patients with drug refractory rheumatoid … Continue reading

SetPoint Medical Employees Dedicate Their Day to Hope Gardens

  Valencia, CA – February 15, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, is proud to share the news that 25 SetPoint employees spent the day on Wednesday, February 14 volunteering at Hope Gardens Family Center in Los Angeles. The facility, run by … Continue reading

SetPoint Medical Reports Positive Results from Two Bioelectronic Medicine Studies at North American Neuromodulation Society Meeting

  Company Presented Positive Data on RA 24-Month Follow-up Study and Current Crohn’s Disease Study Valencia, CA – January 14, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, presented positive data from two clinical studies in rheumatoid arthritis (RA) and Crohn’s disease (CD) at … Continue reading

FDA Approves Investigational Device Exemption for SetPoint Bioelectronic Therapy Clinical Study in Rheumatoid Arthritis

  Valencia, CA – December 11, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, has received Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) to initiate a pilot trial in the U.S. for patients with drug refractory rheumatoid arthritis … Continue reading

SetPoint Medical Presents Early Data Showing Bioelectronic Medicine Accelerates Remyelination in Animal Model of Multiple Sclerosis

  – Data Presented at ECTRIMS-ACTRIMS Multiple Sclerosis Meeting in Paris – Valencia, CA – October 30, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, presented positive data from a study exploring the therapeutic effects of a bioelectronic medicine approach for multiple sclerosis (MS) showing that … Continue reading